Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Equinix Inc (EQIX) vs Twist Bioscience Corp (TWST) Price & Performance

Equinix IncTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Equinix Inc vs Twist Bioscience Corp — how do they compare? Equinix Inc trades at $1,032.41 (market cap $102.95B), while Twist Bioscience Corp trades at $123.13 (market cap $7.82B). The key difference: Equinix Inc is far larger — about 13.2× Twist Bioscience Corp's market cap, and Equinix Inc pays a 1.98% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

EQIXTWST
Market Cap
$102.95B$7.82B
Sector
Real EstateHealth
52-Week High
$1.12K$124.88
52-Week Low
$726.09$24.16
Enterprise Value
$124.08B$7.75B
Dividend Yield
1.98%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Equinix Inc

Equinix (EQIX) trades at $1,042.62, down 0.97% on the day, with strong analyst support (74.5% buy ratings) and a consensus price target of $1,120. The stock shows bullish technical signals with support at $1,040 and resistance at $1,067. Recent Q2 2026 earnings beat expectations with $4.83 EPS versus $4.73 expected, while revenue growth continues at 9.2B in 2025 with improving net margins to 15.63%. The company maintains robust cash flow from operations at $3.9B despite significant capital investments.

EQIX presents a compelling growth story driven by AI infrastructure demand and global digital expansion, though elevated valuation multiples (P/E 67.09) and substantial debt levels ($15.2B total debt) warrant caution. The stock offers dividend income with recent $5.16 payments, but investors should monitor execution risks in capital-intensive expansion and competitive pressures in the data center REIT sector.

Twist Bioscience Corp

Twist Bioscience (TWST) trades at $115.67, up 6.04% in the last session, with bullish technical signals from moving averages and a recent analyst upgrade. Revenue growth is strong, with fiscal 2026 Q3 revenue up 23% year-over-year to $118.4 million, though the company remains unprofitable with negative net income margins. A recent $300 million public offering at $96 per share indicates capital raising for expansion.

The outlook is mixed: robust revenue growth and high analyst buy ratings (78.57%) support upside potential, but persistent losses, cash burn, and high valuation ratios pose significant risks. Investors should weigh growth prospects against financial sustainability concerns.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Equinix Inc

Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.

Read more on EQIX

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST